Video | 15 February 2020 Big pharma is double dipping 1 min RESEARCH AND DEVELOPMENT Medicines made with help from OUR taxes should be accessible to EVERYONE who needs them. SHARE this video and tell our leaders to stand up to Big Pharma’s double-dip profiteering. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies Technical brief | 22 May 2023 Research and development Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done? Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products? Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min Technical brief | 11 November 2022 Transparency Research and development MSF Clinical Trial Transparency Policy Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products? Load More
Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies
Technical brief | 22 May 2023 Research and development Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done?
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products?
Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min
Technical brief | 11 November 2022 Transparency Research and development MSF Clinical Trial Transparency Policy
Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products?
